Spinal Cord Stimulation for Arm and Leg Movement After Stroke
Tests spinal cord stimulation in adults with limb movement problems after stroke.
Plain-language title generated from the registry record
Registry title: Clinical Study of the Efficacy and Safety of Spinal Cord Stimulation in Patients With Limb Motor Dysfunction Following Stroke
Key facts
- Where
- Hangzhou, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have weak limbs on one side of the body after a single stroke at least 6 months ago and who recovered poorly despite regular rehabilitation.
- Age
- 20 to 80 years (inclusive).
- Sex
- All sexes can join.
- Disease stage
- Weakness on one side of the body after a single ischemic or hemorrhagic stroke, at least 6 months ago. Fugl-Meyer upper limb score above 7 and below 45, lower limb score above 5 and below 30. Some sensation still preserved.
- Earlier treatment
- Regular rehabilitation therapy after the stroke, with poor recovery of limb movement.
Main reasons for not taking part
- Severe other diseases or conditions that can harm movement or thinking
- Pressure on spinal cord nerves that could cause severe loss of function
- Pregnant or breastfeeding women
- Use of blood-thinning, antispasmodic or antiepileptic medicines before or during the study
- Other implanted medical devices
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 80 years old?
Source: NCT07627516, who can take part
Where in China
- The Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Trial code
- NCT07627516
- Record updated
- 4 June 2026
- Original description
To assess the efficacy and safety of spinal cord stimulation in treating post-stroke limb motor disorders, we propose to conduct a clinical trial. This study seeks to accumulate additional clinical experience with spinal cord stimulation in patients suffering from post-stroke limb motor disorders and to enhance their quality of life.Read full original descriptionShow less
Clinical Study of the Efficacy and Safety of Spinal Cord Stimulation in Patients With Limb Motor Dysfunction Following Stroke
To assess the efficacy and safety of spinal cord stimulation in treating post-stroke limb motor disorders, we propose to conduct a clinical trial. This study seeks to accumulate additional clinical experience with spinal cord stimulation in patients suffering from post-stroke limb motor disorders and to enhance their quality of life.
Inclusion: Hemiparesis resulting from a single ischemic or hemorrhagic stroke, with a disease duration of ≥6 months; Aged between 20 and 80 years (inclusive); Received regular rehabilitation therapy after stroke but with poor recovery of limb motor function; Fugl-Meyer Assessment upper extremity score >7 and <45, and lower extremity score >5 and <30; Partially preserved sensory function.
Exclusion: Use of anticoagulant, antiplatelet, antispasmodic, or antiepileptic medications prior to enrollment or during the study period; Severe systemic diseases (e.g., neurological disorders other than stroke, cancer, severe circulatory or respiratory diseases, liver or kidney failure, etc.) or other conditions that may impair the subject's motor or cognitive function; Presence of spinal cord-related nerve compression that could cause severe functional impairment; Severe mental illness or intellectual disability that prevents cooperation with treatment or follow-up questionnaires, with a Mini-Mental State Examination (MMSE) score <24; Women who are pregnant or breastfeeding; Severe joint contracture that, in the clinical investigator's opinion, precludes participation in the study; Presence of other implanted medical devices; Severe claustrophobia.